Glycolipid antigen drives rapid expansion and sustained cytokine production by NK T cells

Journal of Immunology

Volumn 171, Issue 8, 2003, Pages 4020-4027

  Crowe, Nadine Y ^a   Uldrich, Adam P ^a   Kyparissoudis, Konstantinos ^a   Hammond, Kirsten J L ^b   Hayakawa, Yoshihiro ^c   Sidobre, Stephané ^b   Keating, Rachael ^a   Kronenberg, Mitchell ^b   Smyth, Mark J ^c   Godfrey, Dale I ^a,d  

^a MONASH UNIVERSITY   (Australia)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD1 ANTIGEN; GAMMA INTERFERON; GLYCOLIPID; INTERLEUKIN 4; T LYMPHOCYTE RECEPTOR;

ANIMAL TISSUE; ANTIGEN PRESENTATION; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOWN REGULATION; IMMUNE RESPONSE; IMMUNOREGULATION; IMMUNOSTIMULATION; INFECTION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL; TUMOR IMMUNITY;

EID: 0141958207     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.8.4020     Document Type: Article

References (36)

1. Godfrey, D. I., K. J. Hammond, L. D. Poulton, M. J. Smyth, and A. G. Baxter. 2000. NKT cells: facts, functions and fallacies. Immunol. Today 21:573.
2. Kronenberg, M., and L. Gapin, 2002. The unconventional lifestyle of NKT cells. Nat. Rev. Immunol. 2:557.
3. Bendelac, A., M. N. Rivera, S. H. Park, and J. H. Roark. 1997. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol. 15:535.
4. + T lymphocytes. Science 268:863.
5. + NKT lymphocytes. J. Immunol. 161:3271.
6. Hong, S. M., D. C. Scherer, N. Singh, S. K. Mendiratta, I. Serizawa, Y. Koezuka, and L. Van Kaer. 1999. Lipid antigen presentation in the immune system: lessons learned from CD1d knockout mice. Immunol. Rev. 169:31.
7. Kawano, T., J. Q. Cui, Y. Koezuka, I. Toura, Y. Kaneko, K. Motoki, H. Ueno, R. Nakagawa, H. Sato, E. Kondo, et al. 1997. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science 278:1626.
8. Hammond, K. J., and D. I. Godfrey. 2002. NKT cells: potential targets for autoimmune disease therapy? Tissue Antigens 59:353.
9. Smyth, M. J., N. Y. Crowe, K. Takeda, H. Yagita, and D. I. Godfrey. 2002. NKT cells: conductors of tumor immunity? Curr. Opin. Immunol. 14:165.
10. Smyth, M. J., and D. I. Godfrey. 2000. NKT cells and tumor immunity-a double-edged sword. Nat. Immunol. 1:459.
11. Nakagawa, R., I. Nagafune, Y. Tazunoki, H. Ehara, H. Tomura, R. Iijima, K. Motoki, M. Kamishohara, and S. Seki. 2001. Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by α -galactosylceramide in mice. J. Immunol. 166:6578.
12. Osman, Y., T. Kawamura, T. Naito, K. Takeda, L. Van Kaer, K. Okumura, and T. Abo. 2000. Activation of hepatic NKT cells and subsequent liver injury following administration of α-galactosylceramide. Eur. J. Immunol. 30:1919.
13. Leite-de-Moraes, M. C., A. Herbelin, C. Gouarin, Y. Koezuka, E. Schneider, and M. Dy. 2000. Fas/Fas ligand interactions promote activation-induced cell death of NK T lymphocytes. J. Immunol. 165:4367.
14. Hayakawa, Y., K. Takeda, H. Yagita, S. Kakuta, Y. Iwakura, L. Van Kaer, I. Saiki, and K. Okumura. 2001. Critical contribution of IFN-γ and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of α-galactosylceramide. Eur. J. Immunol. 31:1720.
15. Eberl, G., and H. R. Macdonald. 1998. Rapid death and regeneration of NKT cells in anti-CD3-ε- or IL-12-treated mice: a major role for bone marrow in NKT cell homeostasis. Immunity 9:345.
16. Matsuda, J. L., O. V. Naidenko, L. Gapin, T. Nakayama, M. Taniguchi, C. R. Wang, Y. Koezuka, and M. Kronenberg. 2000. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 192:741.
17. Brossay, L., M. Chioda, N. Burdin, Y. Koezuka, G. Casorati, P. Dellabona, and M. Kronenberg. 1998. Cd1d-mediated recognition of an α -galactosylceramide by natural killer t cells is highly conserved through mammalian evolution. J. Exp. Med. 188:1521.
18. Sidobre, S., O. V. Naidenko, B. C. Sim, N. R. Gascoigne, K. C. Garcia, and M. Kronenberg. 2002. The Vα14 NKT cell TCR exhibits high-affinity binding to a glycolipid/CD1d complex. J. Immunol. 169:1340.
19. + T cells upon NK T or T cell activation. J. Immunol. 165:4305.
20. Fujii, S., K. Shimizu, M. Kronenberg, and R. M. Steinman. 2002. Prolonged IFN-γ-producing NKT response induced with α -galactosylceramide-loaded DCs. Nat. Immunol. 3:867.
21. + T cells lose NK1.1 expression upon in vitro activation. J. Immunol. 158:5112.
22. Korner, H., D. S. Riminton, D. H. Strickland, F. A. Lemckert, J. D. Pollard, and J. D. Sedgwick. 1997. Critical points of tumor necrosis factor action in central nervous system autoimmune inflammation defined by gene targeting. J. Exp. Med. 186:1585.
23. Komer, H., E. Cretney, P. Wilhelm, J. M. Kelly, M. Rollinghoff, J. D. Sedgwick, and M. J. Smyth. 2000. Tumor necrosis factor sustains the generalized lymphoproliferative disorder (gld) phenotype. J. Exp. Med. 191:89.
24. + T cells and natural killer cells is essential for the antimetastatic effect of α-galactosylceramide. Blood 99:1259.
25. Tough, D. F., and J. Sprent. 1994. Turnover of naive- and memory-phenotype T cells. J. Exp. Med. 179:1127.
26. Hildeman, D. A., Y. Zhu, T. C. Mitchell, P. Bouillet, A. Strasser, J. Kappler, and P. Marrack. 2002. Activated T cell death in vivo mediated by proapoptotic bcl-2 family member bim. Immunity 16:759.
27. Osman, Y., T. Watanabe, Y. Kawachi, K. Sato, K. Ohtsuka, H. Watanabe, S. Hashimoto, Y. Moriyama, A. Shibata, and T. Abo. 1995. Intermediate tcr cells with self-reactive clones are effector cells which induce syngeneic graft-versus-host disease in mice. Cell. Immunol. 166:172.
28. - (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD/Lt) mice by the influence of interleukin (IL)-4 and/or IL-10. J. Exp. Med. 187:1047.
29. Eberl, G., and H. R. MacDonald. 2000. Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells. Eur. J. Immunol. 30:985.
30. Hameg, A., I. Apostolou, M. Leite de Moraes, J. M. Gombert, C. Garcia, Y. Koezuka, J. F. Bach, and A. Herbelin. 2000. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the α-galactosylceramide antigen. J. Immunol. 165:4917.
31. Benlagha, K., A. Weiss, A. Beavis, L. Teyton, and A. Bendelac. 2000. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers. J. Exp. Med. 191:1895.
32. Hammond, K. J., D. G. Pellicci, L. D. Poulton, O. V. Naidenko, A. A. Scalzo, A. G. Baxter, and D. I. Godfrey. 2001. CD1d-restricted NKT cells: an interstrain comparison. J. Immunol. 167:1164.
33. Benlagha, K., T. Kyin, A. Beavis, L. Teyton, and A. Bendelac. 2002. A thymic precursor to the NK T cell lineage. Science 296:553.
34. + CD1d-dependent precursor stage. J Exp. Med. 195:835.
35. + natural killer T cells in the liver is maintained without supply by the thymus during adult life. Immunology 104:135.
36. Crowe, N. Y., M. J. Smyth, and D. I. Godfrey. 2002. A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas. J. Exp. Med. 196:119.